Piriformis Syndrome Treatment Market: Introduction
• Piriformis syndrome is a neuromuscular disorder, wherein the piriformis muscles squeeze the sciatic nerves, causing spasms and buttock pain. Piriformis is a small muscle located behind the gluteus maximus, deep in the buttock. This syndrome also causes pain, numbness, and tingling in the foot and back of legs. Piriformis muscles are important for lower body movement, as these help maintain body balance, walking, and even shifting of weight from one foot to other. These muscles are used in motion of hips and legs, and majorly in sports that involve movement of the thighs. The cause of piriformis syndrome is unknown; however, some estimated causes are irritation in the piriformis muscles or in the sacroiliac joint or hip, tightening or swelling of the muscles in response to or due to injury or spasm or in some cases bleeding in the piriformis muscle area.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B...
Key Drivers, Restrains, and Opportunities of Global Piriformis Syndrome Treatment Market
• Increase in incidence of piriformis syndrome and proper screening & diagnosis of the syndrome are major factors driving the global piriformis syndrome treatment market. Launch of innovative drugs, rise in awareness about diagnosis of the syndrome, and increase in geriatric population are projected to propel the global market. Investments by key players in spreading awareness about the prevalence of piriformis syndrome and its treatments are anticipated to fuel the global piriformis syndrome treatment market. However, there are certain challenges in the diagnosis of the syndrome, especially in developing counties. This is expected to hamper the market. Moreover, complications during surgeries and lack of awareness in developing countries are other factors that are likely to restrain the piriformis syndrome treatment market. In December 2018, a research published on Medscape stated that the incidence ratio of piriformis syndrome is 6 women to 1 man in the U.S. Moreover, the incidence of piriformis syndrome in patients with sciatica is 6% in the country. A study conducted at a local hospital in the U.S. revealed that of the 750 patients with lower back problem (LBP), 45 were suffering from piriformis syndrome. According to study update on NCBI, the estimated new cases of back pain and sciatica is 40 million per year, and incidence rate of piriformis syndrome is around 2.4 million per year.
Request for Covid-19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=c...
Piriformis Syndrome Treatment Market: Segmentation
• The global piriformis syndrome treatment market can be segmented based on treatment, end-user, and region. In terms of treatment, the piriformis syndrome treatment market can be classified into medication, physical therapy, osteopathic manipulative treatment (OMT), prolotherapy, surgery, and others. Based on end-user, the global piriformis syndrome treatment market can be divided into hospitals, clinics, ambulatory surgical centers, and others.
North America to Capture Major Share of Global Piriformis Syndrome Treatment Market
• In terms of region, the global piriformis syndrome treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2020, and the trend is projected to continue during the forecast period. This is due to an increase in incidence of piriformis syndrome, rise in awareness about the causes of piriformis syndrome, surge in healthcare expenditure and diagnosis of the syndrome. Moreover, advanced healthcare facilities, awareness about required surgeries, favorable reimbursement policies, and new products in the market are anticipated to boost the piriformis syndrome treatment market in the region. Europe held the second-largest share of the global market in 2020. Rise in prevalence of piriformis syndrome and government support for research & development are expected to drive the piriformis syndrome treatment market in the region. Increase in the geriatric population and rise in awareness about piriformis syndrome and its treatment are key factors fueling the market in the region. People in other regions are unaware about the diagnosis of piriformis syndrome. This is likely to change due to improving infrastructure and availability of diagnostic tools in developing regions.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=E...
Key Players Operating in Global Piriformis Syndrome Treatment Market
The global piriformis syndrome treatment market is highly concentrated due to the presence of key players. A large number of manufacturers hold major share in their respective regions. Demand for products to treat chronic diseases has increased in emerging as well as developed markets. Growth strategies adopted by leading players are likely to drive the global piriformis syndrome treatment market.
Major players operating in the global piriformis syndrome treatment market are listed below:
• AstraZeneca
• Bayer AG
• Endo Pharmaceuticals, Inc.
• Miracle Stretch, LLC
• Nidd Valley Medical
• Novartis AG
• Omron Healthcare
• Sanofi
• SEIRIN Corporation.
• Teva Pharmaceuticals Industries Ltd.